
G.Osborne
286 posts

G.Osborne
@Asclepius7TM
GPCR pharmacology with structure based drug design 👍





Alongside our partner Kallyope, we are pleased to share the successful identification, validation and nomination of a first #GPCR target to enter a therapeutic discovery program for gastrointestinal diseases. Read more here: bit.ly/3QTfarF #drugdiscovery #GI












We are pleased to announce we have reached a R&D milestone under our collaboration with @abbvie to discover small molecules that modulate GPCRs targeting inflammatory diseases. The achievement of this milestone triggers a payment of US$10 million. bit.ly/3YlMWrk

Today we announced a poster presentation of data from our oral small-molecule orexin receptor 2 (OX2R) agonist discovery pipeline at #SleepEurope 2022. The poster will be presented in Athens on Thurs., Sept. 29 at 12:15pm EEST. Read our press release: investors.centessa.com/news-releases/…










